alzheimer’s
-
New Alzheimer’s drugs have given hope to patients, but researchers warn the risks may outweigh the benefits – Copyright POOL/AFP/File Eugene Hoshiko
-
An anonymous reader quotes a report from the New York Times: A committee of independent advisers to the Food and Drug Administration voted unanimously on Monday that the benefits outweigh the risks of the newest experimental drug for Alzheimer’s disease. Alzheimer’s afflicts more than six million Americans. It has no cure, and there is no…
-
An anonymous reader quotes a report from Science Magazine: Authors of a landmark Alzheimer’s disease research paper published in Nature in 2006 have agreed to retract the study in response to allegations of image manipulation. University of Minnesota (UMN) Twin Cities neuroscientist Karen Ashe, the paper’s senior author, acknowledged in a post on the journal…
-
Long before people develop dementia, they often begin falling behind on mortgage payments, credit card bills and other financial obligations, new research shows. The New York Times: A team of economists and medical experts at the Federal Reserve Bank of New York and Georgetown University combined Medicare records with data from Equifax, the credit bureau,…
-
Pam Belluck reports via the New York Times: Scientists are proposing a new way of understanding the genetics of Alzheimer’s that would mean that up to a fifth of patients would be considered to have a genetically caused form of the disease. Currently, the vast majority of Alzheimer’s cases do not have a clearly identified…
-
A team of scientists seems to have discovered a previously hidden genetic cause of Alzheimer’s. In a new study Monday, the researchers found strong evidence that people carrying two copies of a genetic variation already tied to Alzheimer’s risk are practically destined to develop the neurodegenerative disorder as they get older. As much as 2%…
-
New research is the latest to suggest that sildenafil—the active ingredient in popular erectile dysfunction drug Viagra—might help fend off Alzheimer’s disease. The study found that people taking sildenafil were noticeably less likely to develop Alzheimer’s than similar patients not taking it. The results do not yet prove that the little blue pill is effective…
-
A new study this week points to a potential transmission risk of Alzheimer’s disease. Researchers found evidence in mice that an inherited form of the neurological disorder can be passed on via bone marrow donation. While such a danger has yet to be confirmed in humans and likely to be infrequent if it can happen,…
-
Vaccines may change how the immune system responds to the buildup of toxic proteins that contribute to Alzheimer’s disease. (Credit: Creative Commons)
-
One of the world’s most famous drug classes may have another trick up its sleeve. In a new study, scientists in the UK have found that erectile dysfunction drugs like sildenafil (more widely known as Viagra) are linked to a lowered risk of Alzheimer’s disease, the most common form of dementia. The findings don’t prove…
-
Testing a person’s blood for a type of protein called phosphorylated tau, or p-tau, could be used to screen for Alzheimer’s disease with “high accuracy,” even before symptoms begin to show, a new study suggests. CNN: The study involved testing blood for a key biomarker of Alzheimer’s called p-tau217, which increases at the same time…
-
Stacker mapped states by the share of the 65+ population estimated to have Alzheimer’s disease, using data released by the Alzheimer’s Association. – fizkes // Shutterstock
-
[Dec. 16, 2023: JJ Shavit, The Brighter Side of News]
-
Image: – © AFP/File Philippe LOPEZ A study published in the Journal of Alzheimer’s Disease finds that lifestyle coaching provides cognitive and functional benefits to pre-dementia and Alzheimer’s patients. This is to a level of cognitive benefit not generally seen from currently available Alzheimer’s drugs.
-
Physicists at the Australian National University (ANU) have created a new method combining nanotechnology, artificial intelligence and molecular biology that looks for Alzheimer’s disease protein markers in blood. These markers are clear signs of early neurodegeneration, and early detection is by far the best defense to effectively intervene in Alzheimer’s progression. Although there is no…
-
[Sept. 16, 2023: Staff Writer, The Brighter Side of News]